Article
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNN
Rating:
0.0
Views:
53
Likes:
1
Library:
1
The US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value